-
1دورية أكاديمية
المؤلفون: Kappos, Ludwig, Bar-Or, Amit, Wiendl, Heinz, Paling, David, Williams, Mitzi, Gold, Ralf, Chan, Andrew, Milo, Ron, Das Gupta, Ayan, Karlsson, Goeril, Sullivan, Roseanne, Graham, Gordon, Merschhemke, Martin, Häring, Dieter, Vermersch, Patrick, Hauser, Stephen
المصدر: Neurology and Therapy. 12(5)
مصطلحات موضوعية: ALITHIOS, ASCLEPIOS I/II, Anti-CD20 monoclonal antibody, Benefit-risk, Ofatumumab, Relapsing multiple sclerosis, Self-administration, Subcutaneous
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/9w79q72x
-
2دورية أكاديمية
المؤلفون: Hauser, Stephen L.Aff1, IDs40120023005180_cor1, Kappos, Ludwig, Bar-Or, Amit, Wiendl, Heinz, Paling, David, Williams, Mitzi, Gold, Ralf, Chan, Andrew, Milo, Ron, Das Gupta, Ayan, Karlsson, Goeril, Sullivan, Roseanne, Graham, Gordon, Merschhemke, Martin, Häring, Dieter A., Vermersch, Patrick
المصدر: Neurology and Therapy. 12(5):1491-1515
-
3دورية أكاديمية
المؤلفون: Cross, Anne H, Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J, Cree, Bruce AC, Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin
المصدر: Neurology and Therapy. 11(2)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Vaccine Related, Prevention, Cancer, Immunization, Emerging Infectious Diseases, Infectious Diseases, Infection, Good Health and Well Being, ALITHIOS, Anti-CD20 therapy, B-cell therapy, COVID-19, Ofatumumab, Post-marketing, Relapsing multiple sclerosis, SARS-CoV-2, Vaccination, Clinical sciences, Neurosciences
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/9p1397t0
-
4دورية أكاديمية
المؤلفون: Stephen L. Hauser, Ludwig Kappos, Amit Bar-Or, Heinz Wiendl, David Paling, Mitzi Williams, Ralf Gold, Andrew Chan, Ron Milo, Ayan Das Gupta, Goeril Karlsson, Roseanne Sullivan, Gordon Graham, Martin Merschhemke, Dieter A. Häring, Patrick Vermersch
المصدر: Neurology and Therapy, Vol 12, Iss 5, Pp 1491-1515 (2023)
مصطلحات موضوعية: ALITHIOS, Anti-CD20 monoclonal antibody, ASCLEPIOS I/II, Benefit-risk, Ofatumumab, Relapsing multiple sclerosis, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
5
المؤلفون: Cross, Anne H., Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J., Cree, Bruce A. C, Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin, Universitat Autònoma de Barcelona. Departament de Medicina
المساهمون: Institut Català de la Salut, [Cross AH] Department of Neurology, Washington University, St. Louis, USA. [Delgado S] University of Miami Miller School of Medicine, Miami, USA. [Habek M] University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia. [Davydovskaya M] Moscow State Public Healthcare InsCity Clinical Hospital 24, Moscow, Russia. [Ward BJ] Infectious Diseases Division, Research Institute of the McGill University Health Centre, Montreal, Canada. [Cree BAC] UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, USA. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
Neurology and therapy, vol 11, iss 2مصطلحات موضوعية: ALITHIOS, Vaccine Related, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Relapsing-Remitting [DISEASES], B-cell therapy, Cancer, Anti-CD20 THERAPY, Anti-CD20 therapy, SARS-CoV-2, Prevention, Vaccination, Otros calificadores::Otros calificadores::/terapia [Otros calificadores], COVID-19, Ofatumumab, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple recurrente-remitente [ENFERMEDADES], Emerging Infectious Diseases, Infectious Diseases, Good Health and Well Being, Neurology, Other subheadings::Other subheadings::/therapy [Other subheadings], Relapsing multiple sclerosis, Avaluació de resultats (Assistència sanitària), Immunization, Neurology (clinical), Infection, Esclerosi múltiple - Tractament, Post-marketing, COVID-19 (Malaltia) - Vacunació
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b835b539b7d244ee2268205afb91ca8
https://ddd.uab.cat/record/274987 -
6
المؤلفون: Cross, Anne H., Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J., Cree, Bruce A. C, Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin, Universitat Autònoma de Barcelona. Departament de Medicina
مصطلحات موضوعية: Neurology, SDG 3 - Good Health and Well-being, SARS-CoV-2, Relapsing multiple sclerosis, Vaccination, COVID-19, Ofatumumab, Neurology (clinical), B-cell therapy, Post-marketing, ALITHIOS, Anti-CD20 THERAPY
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1580a33bbb56d491f73467bbb787f9f4
https://ddd.uab.cat/record/274638